$2.6c cash in bank, low overheads, no commitments on work programs. Existing assets are worthless but the company in advanced negotiations with a number of companies
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game